A pilot study of cyclophosphamide, carboplatin, etoposide (CCE), and G-CSF with or without rituximab for cytoreduction and peripheral blood stem cell mobilization in patients with relapsed or refractory lymphomas

✍ Scribed by D.E. Stevenson; A.L. Haroff; D.W. Ririe; J.E. Splichal; D.L. Ornstein; B.J. Heller

• Book ID: 116278805
• Publisher: Elsevier Science
• Year: 2006
• Tongue: English
• Weight: 60 KB
• Volume: 12
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2005.11.372